EFFECT OF TP53 DEFICIENCY AND KRAS SIGNALING ON THE BIOENERGETICS OF COLON CANCER CELLS IN RESPONSE TO DIFFERENT SUBSTRATES: A SINGLE CELL STUDY

Effect of TP53 deficiency and KRAS signaling on the bioenergetics of colon cancer cells in response to different substrates: A single cell study

Metabolic reprogramming is a hallmark of cancer.Somatic mutations in genes involved in oncogenic signaling pathways, including KRAS and TP53, rewire the metabolic machinery in cancer cells.We here set out to determine, at the single cell level, metabolic signatures in human colon cancer cells engineered to express combinations of activating KRAS ge

read more



Identification of MARK2, CCDC71, GATA2, and KLRC3 as candidate diagnostic genes and potential therapeutic targets for repeated implantation failure with antiphospholipid syndrome by integrated bioinformatics analysis and machine learning

BackgroundAntiphospholipid syndrome (APS) is a group of clinical syndromes of thrombosis or adverse pregnancy outcomes caused by antiphospholipid antibodies, which increase the incidence of in vitro fertilization failure in patients with infertility.However, the common mechanism of repeated implantation failure (RIF) with APS is unclear.This study

read more